Li, WenhanUniversität HeidelbergHeidelberg
Publikationsliste einschränken
Publikationsjahre
Publikationstypen
Sprache
Co-Autoren (Uni Heidelberg)
Co-Autoren (extern)
Publikationen in heiBIB 
- Cinci, Marc L.: Targeted delivery of siRNA using transferrin-coupled lipoplexes specifically sensitizes CD71 high expressing malignant cells to antibody-mediated complement attack / Marc Cinci, Srinivas Mamidi, Wenhan Li, Volker Fehring, Michael Kirschfink, 2015. - 9 S.
In: Targeted oncology, ISSN 1776-260X. 10(2015), 3, Seite 405-413
DOI: 10.1007/s11523-014-0345-6
- Liu, Li: Sublytic complement protects prostate cancer cells from tumour necrosis factor‐α‐induced cell death / L. Liu, W. Li, Z. Li and M. Kirschfink, August 2012. - 9 S.
In: Clinical & experimental immunology, ISSN 1365-2249. 169(2012), 2, Seite 100-108
DOI: 10.1111/j.1365-2249.2012.04596.x
- Geis, Nicolas: Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro / Nicolas Geis, Stefanie Zell, Renate Rutz, Wenhan Li, Thomas Giese, Srinivas Mamidi, Stefan Schultz a… , 2010. - 10 S.
In: Current cancer drug targets, ISSN 1873-5576. 10(2010), 8, Seite 922-931
DOI: 10.2174/156800910793357952
- Emlen, Woodruff: Therapeutic complement inhibition : new developments / Woodruff Emlen, Wenhan Li, and Michael Kirschfink, 2010. - 9 S.
In: Seminars in thrombosis and hemostasis, ISSN 1098-9064. 36(2010), 6, Seite 660-668
DOI: 10.1055/s-0030-1262888
- Li, Wenhan: Screening and identification of a novel target specific for hepatoma cell line HepG2 from the FliTrx bacterial peptide library / Wenhan Li, Ping Lei, Bing Yu, Sha Wu, Jilin Peng, Xiaoping Zhao, Huifen Zhu, Michael Kirschfink, and… , 2008. - 9 S.
In: Acta biochimica et biophysica Sinica, ISSN 1745-7270. 40(2008), 5, Seite 443-451
DOI: 10.1111/j.1745-7270.2008.00412.x
